Neuroblastoma: Current Imaging and Therapeutics
Journal Title: Journal of Cancer and Tumor International - Year 2015, Vol 2, Issue 3
Abstract
Neuroblastoma is the most common solid abdominal tumor in children under the age of 2 years and accounts for approximately 15% of childhood mortality due to cancer. Its clinical behavior can vary from spontaneous regression to rapid fatal progression and anywhere in between (e.g. differentiation into benign tumors). Unfortunately, 50% of patients already have metastases at presentation. This marked clinical variability and often advanced presentation at time of diagnosis must be addressed with improved imaging and new treatments, particularly through focus on expanded drug development. Current treatment regimens (surgical resection, chemotherapy, and radiotherapy) have proven to be inadequate for treating advanced disease and frequently cause severe side effects that make them intolerable for many children. Promising new therapies include anti-adhesion therapy and immunotherapy, which uses antibodies to trigger a patient’s own immune system to destroy neuroblastoma cells. Of particular interest in the realm of anti-adhesion is attenuation of NF-κB over-activation. Increased NF-κB activity is thought to play a role in the development of tumor resistance to chemotherapeutic agents and radiation. Therefore, novel drugs to attenuate NF-kB activity could revolutionize treatment by increasing overall treatment effectiveness and allowing for reduced drug and radiation doses for dose-sensitive patients.
Authors and Affiliations
Xudong Huang, Ami K. Patel, Krupa K. Patel, Eva-Maria Ratai
Keywords
Related Articles
- EP ID EP242956
- DOI 10.9734/JCTI/2015/16165
- Views 100
- Downloads 0
Angiotensin II Type 2 Receptor: A Novel Modulator of Inflammation in Pancreatic Ductal Adenocarcinoma through Regulation of NF-ΚB Activity
Aims: The aim of this study was to explore potential pro-inflammatory, pro-migratory and pro-invasive roles of angiotensin II type 2 receptor (AT2R) in pancreatic ductal adenocarcinoma (PDAC) cells. Study Design: AT2R-s...
Outcome and Predictive Factors of Radiation Therapy for Medulloblastoma: Mansoura Experience
Background: Medulloblastomas are the most common infratentorial malignant brain tumors with an incidence rate of 0.5 in 100.000 typically arising in childhood at age 5-9 years. Aim of Work: Exploring the epidemiological...
Antitumour Activity of Xanthium strumarium L. on Human Cervical Cancer HeLa Cells
Aim: The present investigation was aimed at assessing the antiproliferative and apoptotic potential of the hydroalcoholic extract of X. strumarium on HeLa cell line. Study Design: Antitumour activity of Xanthium strumar...
The Silver, Cobalt, Chromium, Iron, Mercury, Rubidium, Antimony, Selenium and Zinc Contents in Human Bone Affected by Ewing's Sarcoma
Aims: To clarify the role of trace elements in the etiology and the pathogenesis of the Ewing's sarcoma, a non-destructive neutron activation analysis with high resolution spectrometry of long-lived radionuclides were pe...
Factors Contributing to Delayed Breast Cancer Presentation: A Prospective Study at Parirenyatwa Group of Hospitals, Harare, Zimbabwe 2010-2013
Background: Breast cancer is one of the most common female cancers in Zimbabwe. A considerable proportion of patients delay presentation, leading to high morbidity and mortality. Delay in presentation can either be provi...